JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded)
Objectives The objective of this study was to report the experience with rituximab treatment in a case series of patients with long-standing systemic sclerosis-associated interstitial lung disease (SSc-ILD).